FDA Refines Forms to Monitor Doctors' Drug Trial Finances
Published Date: 5/1/2025
Notice
Summary
The FDA wants to keep better track of clinical investigators by updating their financial disclosure forms. This affects doctors and researchers who test new medicines and devices, making sure they’re honest about money ties. The government is asking for approval to collect this info, aiming to keep things fair without costing extra time or money.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Updated Financial Disclosures for Investigators
The FDA is proposing updated financial disclosure forms to better track clinical investigators — the doctors and researchers who test new medicines and devices. The proposed collection was submitted to the Office of Management and Budget for review under the Paperwork Reduction Act, and the agency says it aims to keep things fair without costing extra time or money.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in